K2M Group Holdings (KTWO) Receiving Somewhat Favorable News Coverage, Report Finds
News coverage about K2M Group Holdings (NASDAQ:KTWO) has trended somewhat positive recently, according to Accern. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. K2M Group Holdings earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned news stories about the medical device company an impact score of 45.8480410627977 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Several research firms recently commented on KTWO. BidaskClub cut K2M Group Holdings from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Needham & Company LLC reaffirmed a “buy” rating on shares of K2M Group Holdings in a report on Wednesday, August 2nd. Oppenheimer Holdings, Inc. set a $29.00 price target on K2M Group Holdings and gave the company a “buy” rating in a report on Wednesday, August 2nd. Cowen and Company set a $28.00 price target on K2M Group Holdings and gave the company a “buy” rating in a report on Thursday, August 17th. Finally, Zacks Investment Research raised K2M Group Holdings from a “sell” rating to a “hold” rating in a report on Saturday, August 5th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $25.00.
K2M Group Holdings (NASDAQ:KTWO) traded down $0.05 during mid-day trading on Friday, reaching $18.99. The company’s stock had a trading volume of 266,452 shares, compared to its average volume of 414,238. The company has a quick ratio of 1.67, a current ratio of 3.06 and a debt-to-equity ratio of 0.29. K2M Group Holdings has a one year low of $17.23 and a one year high of $25.99.
K2M Group Holdings (NASDAQ:KTWO) last posted its earnings results on Wednesday, November 1st. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.01). The business had revenue of $62.65 million for the quarter, compared to analyst estimates of $62.69 million. K2M Group Holdings had a negative return on equity of 16.02% and a negative net margin of 16.22%. K2M Group Holdings’s revenue was up 5.6% compared to the same quarter last year. During the same period last year, the business earned ($0.19) EPS. equities research analysts anticipate that K2M Group Holdings will post -0.86 earnings per share for the current fiscal year.
In other K2M Group Holdings news, insider John Philip Md Kostuik sold 1,332 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $23.30, for a total transaction of $31,035.60. Following the completion of the sale, the insider now owns 200,629 shares of the company’s stock, valued at $4,674,655.70. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 5.80% of the stock is owned by company insiders.
WARNING: This piece was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was stolen and republished in violation of international copyright & trademark laws. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/18/k2m-group-holdings-ktwo-receiving-somewhat-favorable-news-coverage-report-finds.html.
About K2M Group Holdings
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Receive News & Stock Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related stocks with our FREE daily email newsletter.